Bryan Love

Has grant

Associate Professor

University of South Carolina

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Bryan Love is an Associate Professor at the University of South Carolina. His research primarily focuses on healthcare outcomes, including opioid prescriptions, antibiotic therapies, and economic evaluations in various medical conditions. Recent publications examine the impacts of FDA approvals and healthcare practices on patient outcomes, particularly in relation to Alzheimer's disease and Hepatitis C virus treatments. He is dedicated to exploring innovative healthcare solutions and the role of social media in medical education.

Recent Grants

Grant: Close

Antibiotics Received in the First Year of Life and Odds of Food Allergy in Children

Open Date: 2012-04-01

Close Date: 2013-09-01

Articles (8)

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Ismaeel Yunusa

Assistant Professor

University of South Carolina

UNITED STATES

View details

Michael D. Wyatt

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bryan Love

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (8)

Impacts of FDA approval and Medicare restriction on antiamyloid therapies for Alzheimer's disease: patient outcomes, healthcare costs, and drug development

Associations Between Opioid Prescriptions and Use of Hospital-Based Services Among US Adults with Longstanding Physical Disability or Inflammatory Conditions Compared to Other Adults in the Medical Expenditure Panel Survey, 2010–2015

Effectiveness of Conjugate and Polysaccharide Pneumococcal Vaccines for Prevention of Severe Pneumococcal Disease Among Inflammatory Bowel Disease Patients

The impact of statin use prior to intensive care unit admission on critically ill patients with sepsis

Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review

Changes in Cost-Effectiveness for Chronic Hepatitis C Virus Pharmacotherapy: The Case for Continuous Cost-Effectiveness Analyses.

Healthcare practitioners’ views of social media as an educational resource

Microbes as Drugs: The Potential of Pharmabiotics

Collaborators (2)

Ismaeel Yunusa

Michael D. Wyatt

Make your next move.